405,246 Shares in The Cooper Companies, Inc. $COO Bought by Norges Bank

Norges Bank bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 405,246 shares of the medical device company’s stock, valued at approximately $33,214,000. Norges Bank owned about 0.21% of Cooper Companies as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also bought and sold shares of COO. Wellington Management Group LLP lifted its position in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Diamond Hill Capital Management Inc. lifted its position in Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. JANA Partners Management LP bought a new position in Cooper Companies during the third quarter valued at $166,917,000. Capital World Investors lifted its position in Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after purchasing an additional 2,159,233 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its position in Cooper Companies by 98.8% during the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after purchasing an additional 1,683,561 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the subject of several research reports. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Citigroup restated a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Needham & Company LLC lowered their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday. Finally, BNP Paribas Exane lowered their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Cooper Companies presently has an average rating of “Hold” and an average price target of $82.64.

Cooper Companies Price Performance

Cooper Companies stock opened at $66.79 on Tuesday. The firm has a 50-day moving average price of $64.99 and a 200-day moving average price of $74.50. The firm has a market capitalization of $13.03 billion, a PE ratio of 56.60, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.